BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: A large series in a BRAF V600E-prevalent population

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3693-3700

  Kim, Sun Wook ^a   Lee, Ji In ^a   Kim, Jong Won ^a   Ki, Chang Seok ^a   Oh, Young Lyun ^a   Choi, Yoon La ^a   Shin, Jung Hee ^a   Kim, Hee Kyung ^a   Jang, Hye Won ^a   Chung, Jae Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; OLIGONUCLEOTIDE; BRAF PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; ASPIRATION CYTOLOGY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID CARCINOMA; THYROID NODULE; GENETICS; MIDDLE AGED; MUTATION; NEEDLE BIOPSY; NUCLEOTIDE SEQUENCE; PAPILLARY CARCINOMA; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; SENSITIVITY AND SPECIFICITY; THYROID NEOPLASMS; THYROID NODULE;

EID: 77955351326     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2795     Document Type: Article

References (29)

1. Hegedüs L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771
2. Gharib H, Papini E 2007 Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am 36:707-735, vi
3. Gershengorn MC, McClung MR, Chu EW, Hanson TA, Weintraub BD, Robbins J 1977 Fine-needle aspiration cytology in the preoperative diagnosis of thyroid nodules. Ann Intern Med 87:265-269
4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
5. Schmitt FC 2006 Thyroid cytology: FNA is still the best diagnostic approach. Cytopathology 17:211-212
6. Kelman AS, Rathan A, Leibowitz J, Burstein DE, Haber RS 2001 Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid 11:271-277
7. Lewis CM, Chang KP, Pitman M, Faquin WC, Randolph GW 2009 Thyroid fine-needle aspiration biopsy: variability in reporting. Thyroid 19:717-723
8. Borget I, Vielh P, Leboulleux S, Allyn M, Iacobelli S, Schlumberger M, de Pouvourville G 2008 Assessment of the cost of fine-needle aspiration cytology as a diagnostic tool in patients with thyroid nodules. Am J Clin Pathol 129:763-771
9. Oertel YC 2009 Thyroid fine-needle aspiration. Am J Clin Pathol 132:308
10. Schmitt FC, Longatto-Filho A, Valent A, Vielh P 2008 Molecular techniques in cytopathology practice. J Clin Pathol 61:258-267
11. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63:1454-1457
12. Melillo RM, Castellone MD, Guarino V, De Falco V, Cirafici AM, Salvatore G, Caiazzo F, Basolo F, Giannini R, Kruhoffer M, Orntoft T, Fusco A, Santoro M 2005 The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells. J Clin Invest 115:1068-1081
13. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 28:742-762
14. Guan H, Ji M, Bao R, Yu H, Wang Y, Hou P, Zhang Y, Shan Z, Teng W, Xing M 2009 Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer. J Clin Endocrinol Metab 94:1612-1617
15. Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park do J, Lee HS, Cho BY, Lee ES, Kim SW 2006 Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Clin Endocrinol (Oxf) 65:660-666
16. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098
17. Kim SK, Kim DL, Han HS, Kim WS, Kim SJ, Moon WJ, Oh SY, Hwang TS 2008 Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules. Diagn Mol Pathol 17:118-125
18. Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV 2006 BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid. Diagn Mol Pathol 15:136-143
19. Xing M, Tufano RP, Tufaro AP, Basaria S, Ewertz M, Rosenbaum E, Byrne PJ, Wang J, Sidransky D, Ladenson PW 2004 Detection of BRAF mutation on fine needle aspiration biopsy specimens: a new diagnostic tool for papillary thyroid cancer. J Clin Endocrinol Metab 89:2867-2872
20. Xing M, Clark D, Guan H, Ji M, Dackiw A, Carson KA, Kim M, Tufaro A, Ladenson P, Zeiger M, Tufano R 2009 BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for pre-operative risk stratification in papillary thyroid cancer. J Clin Oncol 27:2977-2982
21. Jarry A, Masson D, Cassagnau E, Parois S, Laboisse C, Denis MG 2004 Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E. Mol Cell Probes 18:349-352
22. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404
23. Rowe LR, Bentz BG, Bentz JS 2007 Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis. J Clin Pathol 60:1211-1215
24. Kwak JY, Kim EK, Kim JK, Han JH, Hong SW, Park TS, Choi JR 2010 Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAF(V600E) mutation in FNAB samples of thyroid nodules in BRAF(V600E) mutation-prevalent area. Head Neck 32:490-498
25. Moon WJ, Jung SL, Lee JH, Na DG, Baek JH, Lee YH, Kim J, Kim HS, Byun JS, Lee DH 2008 Benign and malignant thyroid nodules: US differentiation - multicenter retrospective study. Radiology 247:762-770
26. Chun JY, Kim KJ, Hwang IT, Kim YJ, Lee DH, Lee IK, Kim JK 2007 Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res 35:e40
27. Xing M 2008 Recent advances in molecular biology of thyroid cancer and their clinical implications. Otolaryngol Clin North Am 41:1135-1146, ix
28. Fagin JA, Mitsiades N 2008 Molecular pathology of thyroid cancer: diagnostic and clinical implications. Best Pract Res Clin Endocrinol Metab 22:955-969
29. Gharib H, Papini E, Valcavi R, Baskin HJ, Crescenzi A, Dottorini ME, Duick DS, Guglielmi R, Hamilton Jr CR, Zeiger MA, Zini M 2006 American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63-102